IRCAD recently hosted MMI – Medical Microinstruments, currently the world’s sole developer of a robotic platform dedicated to super-microsurgery. This technology represents a significant leap forward, allowing surgeons to operate on ultra-fine anatomical structures with unprecedented precision.
The visit centered on a future strategic collaboration, focusing on the development and clinical evaluation of MMI’s robotic technology, as well as the establishment of specialized training programs. This rapidly evolving field is gaining traction in several medical sectors, including innovative therapeutic approaches for neurodegenerative conditions such as Alzheimer’s disease. IRCAD remains committed to fostering innovation and excellence in surgical education through such high-level industrial partnerships.
Key participants:
– Mr. Alessandro Midiri, Training & Education Director EU – Professional Education
– Mr. Michael Ghattas, Sr. Sales Director Direct Markets